9/22/20 - Leaderboard - Pharma

Hepatitis B vaccine

Available from Drugdu Technology Co., Ltd

[Specification]0.5ml per container.0.5 ml per single human dose containing 10 μg of HBsAg.
[Eligibles]The subjects susceptible to hepatitis B virus, under 16 years of age, especially newborns born to HBsAg and/to HBeAg-positive mothers
[Action and use]The product can induce immunity against hepatitis B virus in recipients following immunization.It is used to prevent hepatitis B.
[Shelf life] 36 months
•Technology acquisition from Merck
• First product not containing thiomersal •The total market share are 23%,16% and 24% in China from 2013-2015, the annual production reaches 30million doses.Nearly 300 million people were vaccinated.
• First develop low non-reponse crowd HB vaccine • Being registration in Philippines、Pakistan、Nepal 、 Cote d' Ivoire, and we had received the GMP certificate from Philippines.
•Has been exported Semi-finished product of Hep B vaccine to Pakistan.
•We Play an Important Role in Control of HBV in China.

Rate and Review Drugdu Technology Co., Ltd

Rating: 0 - 0 reviews
Let users know what you would have wanted to know about this company.
Click on a star to rate this company
  Privacy Policy.
When writing a review, please adhere to the Review Guidelines.